Open original FDA record ↗Recall record
- FDA identifier
- Z-0140-2027
- Company in FDA record
- Becton Dickinson & Co.
- FDA classification date
- Oct 9, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Potential for quality control failures with Klebsiella pneumoniae ATCC BAA-1705 when using the CPO Ambler classification feature.
Source facts
- Action
- Beckton Dickenson (BD) notified consignees on about 08/13/2026 via mailed and emailed "URGENT: Medical Device Correction" letter. Clinical users were instructed to do the following: 1. Do not report CPO Ambler classification results generated from affected BD Phoenix CPO detect 6-well panels. 2. Do not release Ambler classification information from BD Phoenix panels on patient reports, laboratory information system reports, electronic health records, or other clinical reporting outputs. 3. CPO positive results, other resistance marker results, and any antimicrobial AST MIC and/or SIR result from the BD Phoenix panels are unaffected and may still be reported according to routine laboratory reporting practice. 4. Confirmatory testing to verify appropriate Ambler Classification should be determined and performed in accordance with established laboratory procedures. 5. There are no recommendations regarding results review or sample retesting. Customers were instructed to ensure the contents of the notification are read and understood, share and post the customer letter within each facility network, forward to any customers to whom product may have been distributed to. Additionally, customers were instructed to complete and return the provided Customer Response Form. BD is investigating the root cause and will implement appropriate corrective actions to rectify this issue as soon as possible. **UPDATE 09/02/2026: Firm expanded recall and sent updated notification to include an additional product code. Instructions remained the same.
- Initiated
- 2026-08-13
- Root cause
- Under Investigation by firm
- Distribution
- US Nationwide distribution.
- Recall number
- Z-0140-2027
- Recall status
- Open, Classified
- CDRH record ID
- 222790
- FDA classified
- 2026-10-09
- Recall event number
- 99725